Cardiovascular and Hematological Disorders - Drug Targets
SJR0.236
AE
AEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.236 | Q4 | 34.4% | |
| 2024 | — | — | 0.235 | Q3 | 37.1% | |
| 2023 | — | — | 0.258 | Q3 | 44.0% | |
| 2022 | — | — | 0.270 | Q3 | 47.3% | |
| 2021 | — | — | 0.300 | Q3 | 51.4% | |
| 2020 | — | — | 0.365 | Q3 | 56.6% | |
| 2019 | — | — | 0.330 | Q3 | 55.5% | |
| 2018 | — | — | 0.293 | Q3 | 49.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1871-529X
ISSN
2212-4063
country
AEcoverage
2006-2026